Last June retired pediatrician Dr. Ora Wells was diagnosed with Alzheimer’s Disease. At 2 p.m., Sunday, March 30 the ...

AL002 misses Phase 2 goal in early Alzheimer's. Key Phase 3 data for latozinemab in 2025. Click here to read why ALEC is a ...

A man is wanted in connection with the theft of clinical research samples from a facility in Wellington earlier this year, ...

Noon, is tackling ALS and other neurological disorders with a bold, multi-targeted approach. Fueled by a personal encounter with an ALS advocate, Ben-Noon assembled a team of top scientists to develop ...

WELLINGTON, Fla. (CBS12) — The search is on for a man accused of stealing $75,000 worth of clinical research samples in ...

Since Alzheimer’s advanced stage has no cure right now, the entire focus of Zentara is on prevention. For this purpose, it has identified two goals: make early Alzheimer’s diagnosis cheaper and give ...

Obesity is a major global health issue, increasing the risk of heart disease, diabetes, and high blood pressure. Despite many ...

Alzheimer’s research requires studies that can last for decades, said Dr. Thomas Grabowski, the center’s director and a professor of radiology and neurology at the UW School of Medicine. Those studies ...

A new international study has identified key genetic factors that may protect against Alzheimer’s disease (AD), offering ...

Chicago area scientists have identified the genes that drive the process of Alzheimer’s disease and are working to make the drug Lecanemab even better by identifying which genes are active ...

Discover how a natural compound found in these common herbs could enhance cognitive function and ease inflammation.

New research suggests enhancing the brain’s own immune cells could help clear plaques associated with Alzheimer’s disease.